Answers are grounded in this paper and cite their sources.
Background Olfactory dysfunction substantially affects olfaction-related quality of life, daily functioning, safety, and well-being, yet a validated, comprehensive, Hebrew, olfaction-specific patient-reported outcome measure is unavailable.Objectives To translate, culturally adapt, and validate the Hebrew version of the Questionnaire of Olfactory Disorders (He-QOD).Methods This prospective cross-sectional study included 90 patients with OD and 48 healthy controls. Participants completed the He-QOD, Sniffin’ Sticks threshold-discrimination-identification (TDI) testing, and a Hebrew-adapted University of Pennsylvania Smell Identification Test (UPSIT). Thirty-three participants underwent retesting after at least 4 weeks. Internal consistency, test-retest reliability, known-group validity, convergent validity, and discriminative ability were evaluated.Results The total He-QOD had excellent internal consistency (Cronbach’s alpha = 0.931) and test-retest reliability (intraclass correlation coefficient = 0.971). Patients had higher total and domain scores than controls (all p < 0.001). Total He-QOD score correlated inversely with TDI (ρ = −0.57, p < 0.001) and UPSIT scores (ρ = −0.56, p < 0.001). Areas under receiver operating characteristic curves ranged from 0.833 to 0.846.Conclusion The He-QOD is a reliable and valid tool for assessing the patient-reported burden of OD among Hebrew-speaking populations. Its association with two psychophysical assessments supports its use alongside objective testing in clinical and research settings.
No takes yet. Share an insight, caveat, or question.
Peled et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: